About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 120 record(s)
Req # A-2021-000744
Adverse Drug Reaction (ADR) for Proctofoam HC. Report number: 000949876.Organization: Health Canada
September 2021
Req # A-2021-000751
Why Health Canada launched consultations titled: Proposed new guidance for Novel Food Regulations focused on plant breeding, which were held between March 25, 2021 and May 24, 2021. Who asked for these consultations and why? All documents (emails, letters, minutes from meetings, etc.) associated with the requests and the discussions RESULTING in these consultations.Organization: Health Canada
September 2021
Req # A-2021-000756
Health Canada’s total spending on translation services under Request for Standing Offers (RFSO), Translation Services, Requisition Reference no. 1000211711 between July 1st 2019 to June 30 2020 and between July 1st 2020 and June 30th 2021. Detailed list of the suppliers used under this RFSO along with the dollar amount spent with each supplier.Organization: Health Canada
September 2021
Req # A-2021-000759
Adverse Reaction Reports (AERs). Report numbers: 000947520, 000947522, 000948946, 000949078, 000949632, 000950518.Organization: Health Canada
September 2021
Req # A-2021-000789
The Chief Public Health Officer of Canada - Biography (https://www.canada.ca/en/public-health/corporate/organizational-structure/canada-chief-public-health-officer/biography.html) states that Dr. Tam has over 55 peer-reviewed journal publications in public health. Request all emails and documents that substantiate the statement and verify the legitimacy that "Dr. Tam has over 55 peer-reviewed journal publications in public health". This includes but is not limited to Dr. Tam's application / CV provided as part of the recruitment process for Canada's Chief Public Health Officer.Organization: Health Canada
September 2021
Req # A-2021-000790
Adverse Drug Reaction (ADR) for Alburex-5. Report number: 000935543.Organization: Health Canada
September 2021
Req # A-2021-000791
Risk-Benefit Analysis completed on decision making around masking in public spaces (both indoor and outdoor) and businesses.Organization: Health Canada
September 2021
Req # A-2021-000795
Adverse Drug Reaction (ADR) for Privigen. Report number: 000945071.Organization: Health Canada
September 2021
Req # A-2021-000802
Adverse Drug Reaction (ADR) for GLUCOSE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM CITRATE. Report number: 000925771.Organization: Health Canada
September 2021
Req # A-2021-000825
Adverse Drug Reaction (ADR) for METFORMIN HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE. Report number: E2B_03506859.Organization: Health Canada
September 2021